Form 4 holding
Chief Scientific Officer
Skye Bioscience, Inc.
- Security class
- Common Stock
- Shares / value
- 81,242
- Estimated value
- $147,251
- Report date
- 23 Apr 2025
- Price
- $1.81
- Ownership
- Direct
Christopher Twitty
Insider Reports History
- Reporting-owner location
- Bridgewater, NJ
- Latest reporting-owner signature
-
/s/ Punit S. Dhillon, as Attorney-in-Fact for Christopher Twitty
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Christopher Twitty
Form 4 holding
Director
Larkspur Health Acquisition Corp.
- Security class
- Class B common stock
- Shares / value
- 8,631
- Estimated value
- Report date
- 06 Jan 2022
- Price
- Ownership
- Direct
- Underlying class
- Class A common stock
- Underlying amount
Form 4 holding
Chief Scientific Officer
Skye Bioscience, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 31 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Christopher Twitty
4
SKYE
Skye Bioscience, Inc.
- Report period
- 31 Mar 2026
- Transactions
- 12
- Transaction value
- $0
- Accepted by SEC
- 02 Apr 2026, 18:21
- Role
- Chief Scientific Officer
- Next action
- Open filing details
4
SKYE
Skye Bioscience, Inc.
- Report period
- 06 Feb 2026
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 09 Feb 2026, 20:54
- Role
- Chief Scientific Officer
- Next action
- Open filing details
3
SKYE
Skye Bioscience, Inc.
- Report period
- 23 Apr 2025
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 25 Apr 2025, 16:03
- Role
- Chief Scientific Officer
- Next action
- Open filing details
4
ZVSA
Larkspur Health Acquisition Corp.
- Report period
- 06 Jan 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 Mar 2022, 16:30
- Role
- Director
- Next action
- Open filing details
3
ZVSA
Larkspur Health Acquisition Corp.
- Report period
- 20 Dec 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 20 Dec 2021, 17:21
- Role
- Director
- Next action
- Open filing details